Explore Our Comprehensive Life Sciences Industry Research Reports
P
2024
The global biomarkers market was valued at $46.4 billion in 2023, and is projected to reach $134.2 billion by 2033, growing at a CAGR of 11.2% from 2024 to 2033.
Report Code : A00021 | Pages : 347 | Category : Life Sciences
P
2015
Global Cardiac Biomarkers Market is expected to garner $2,085.9 million by 2020, registering a CAGR of 18.9% during the forecast period 2015-2020. The prevention of cardiac diseases by ...
Report Code : A00219 | Pages : 103 | Category : Life Sciences
U
2024
Renal biomarkers help diagnose or identify the patients at risk of developing kidney diseases, by measuring their blood or urine levels. They are commonly released in acute or chronic kidney injuries, which are characterized by the rapid or gradual loss of kidney function resulting into serous clinical implications.
Report Code : A00538 | Category : Life Sciences
P
2020
The cancer biomarkers market was valued at $10,944.08 million in 2019, and is projected to reach $26,979.50 million by 2027, registering a CAGR of 11.8% from 2020 to 2027.Cancer biomarkers are traceable substances or molecules that indicate the existence of cancerous cells in the body.
Report Code : A01124 | Pages : 338 | Category : Life Sciences
P
2022
The global neurological biomarkers market was valued at $5.4 billion in 2021, and is projected to reach $18.9 billion by 2031, growing at a CAGR of 13.6% from 2022 to 2031.
Report Code : A03215 | Pages : 141 | Category : Life Sciences
U
2024
Biomarkers are minimally or non-invasive tools used in imaging technology to provide clear imaging of oncology tumors & other problems and also eliminate the chance of radiation exposure ...
Report Code : A03794 | Category : Life Sciences
P
2021
The global cardiac biomarkers testing market was valued at $9,766.93 million in 2020, and is projected to reach $28,098.07 million by 2030, registering a CAGR of 10.9% from 2021 to 2030.
Report Code : A04921 | Pages : 235 | Category : Life Sciences
P
2019
The biomarker technologies market accounted for $21,594 million in 2018, and is expected to reach $58,508 million by 2026, registering a CAGR of 13.2% from 2019 to 2026.
Report Code : A04930 | Pages : 255 | Category : Life Sciences
P
2023
The U.S. Neurological Biomarkers Market study provides detailed analysis on major drivers, restraints, trends, opportunities, and key player strategies impacting overall performance of market throughout the forecast period.
Report Code : A103974 | Pages : 80 | Category : Life Sciences
P
2023
The Canada Neurological Biomarkers Market study provides detailed analysis on major drivers, restraints, trends, opportunities, and key player strategies impacting overall performance of market throughout the forecast period.
Report Code : A103975 | Pages : 87 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.